ArticleCancer communications (London, England)2019

Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies.

Trace M Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.